Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 32% ± 11% | |
peripheral blood | 17 studies | 38% ± 10% | |
intestine | 10 studies | 27% ± 13% | |
kidney | 9 studies | 28% ± 11% | |
eye | 8 studies | 28% ± 11% | |
brain | 8 studies | 31% ± 11% | |
bone marrow | 5 studies | 25% ± 7% | |
liver | 5 studies | 37% ± 18% | |
lymph node | 5 studies | 38% ± 5% | |
pancreas | 4 studies | 45% ± 13% | |
uterus | 4 studies | 39% ± 10% | |
prostate | 4 studies | 20% ± 6% | |
breast | 4 studies | 29% ± 5% | |
placenta | 3 studies | 43% ± 18% | |
adrenal gland | 3 studies | 33% ± 11% | |
skin | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 15540.95 | 1445 / 1445 | 100% | 275.75 | 183 / 183 |
ovary | 100% | 15325.15 | 180 / 180 | 100% | 209.16 | 430 / 430 |
prostate | 100% | 12317.20 | 245 / 245 | 100% | 322.57 | 502 / 502 |
skin | 100% | 18481.17 | 1809 / 1809 | 100% | 420.92 | 472 / 472 |
stomach | 100% | 11097.21 | 359 / 359 | 100% | 283.25 | 286 / 286 |
lung | 100% | 13807.93 | 578 / 578 | 100% | 378.17 | 1154 / 1155 |
uterus | 100% | 15494.91 | 170 / 170 | 100% | 381.36 | 458 / 459 |
kidney | 100% | 10571.52 | 89 / 89 | 100% | 225.93 | 899 / 901 |
breast | 100% | 14752.19 | 459 / 459 | 100% | 360.88 | 1115 / 1118 |
thymus | 100% | 12255.96 | 653 / 653 | 100% | 328.75 | 603 / 605 |
intestine | 100% | 15001.31 | 966 / 966 | 100% | 313.38 | 525 / 527 |
liver | 100% | 6551.72 | 225 / 226 | 100% | 200.95 | 405 / 406 |
bladder | 100% | 15355.81 | 21 / 21 | 99% | 333.06 | 500 / 504 |
pancreas | 99% | 6409.23 | 325 / 328 | 100% | 265.96 | 178 / 178 |
brain | 99% | 8455.54 | 2610 / 2642 | 100% | 283.89 | 705 / 705 |
adrenal gland | 100% | 17312.70 | 258 / 258 | 98% | 208.18 | 225 / 230 |
adipose | 100% | 14379.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 15241.84 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 294.71 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 509.19 | 29 / 29 |
muscle | 100% | 15800.06 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 13875.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 425.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 172.30 | 1 / 1 |
heart | 98% | 10927.84 | 840 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 12545.79 | 898 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032508 | Biological process | DNA duplex unwinding |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0045087 | Biological process | innate immune response |
GO_0071480 | Biological process | cellular response to gamma radiation |
GO_0097680 | Biological process | double-strand break repair via classical nonhomologous end joining |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0048660 | Biological process | regulation of smooth muscle cell proliferation |
GO_0000725 | Biological process | recombinational repair |
GO_0071475 | Biological process | cellular hyperosmotic salinity response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0071481 | Biological process | cellular response to X-ray |
GO_0000723 | Biological process | telomere maintenance |
GO_0045621 | Biological process | positive regulation of lymphocyte differentiation |
GO_0002218 | Biological process | activation of innate immune response |
GO_0006266 | Biological process | DNA ligation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0000783 | Cellular component | nuclear telomere cap complex |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005958 | Cellular component | DNA-dependent protein kinase-DNA ligase 4 complex |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0070418 | Cellular component | DNA-dependent protein kinase complex |
GO_0043564 | Cellular component | Ku70:Ku80 complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0070419 | Cellular component | nonhomologous end joining complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0051575 | Molecular function | 5'-deoxyribose-5-phosphate lyase activity |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0042162 | Molecular function | telomeric DNA binding |
GO_0045027 | Molecular function | DNA end binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0003691 | Molecular function | double-stranded telomeric DNA binding |
GO_0003678 | Molecular function | DNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0030332 | Molecular function | cyclin binding |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | XRCC6 |
Protein name | X-ray repair cross complementing 6 X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6) |
Synonyms | G22P1 |
Description | FUNCTION: Single-stranded DNA-dependent ATP-dependent helicase that plays a key role in DNA non-homologous end joining (NHEJ) by recruiting DNA-PK to DNA . Required for double-strand break repair and V(D)J recombination . Also has a role in chromosome translocation . Has a role in chromosome translocation . The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner . It works in the 3'-5' direction . During NHEJ, the XRCC5-XRRC6 dimer performs the recognition step: it recognizes and binds to the broken ends of the DNA and protects them from further resection . Binding to DNA may be mediated by XRCC6 . The XRCC5-XRRC6 dimer acts as a regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold . The XRCC5-XRRC6 dimer is probably involved in stabilizing broken DNA ends and bringing them together . The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step . Probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks . 5'-dRP lyase activity allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined . The XRCC5-XRRC6 dimer together with APEX1 acts as a negative regulator of transcription . In association with NAA15, the XRCC5-XRRC6 dimer binds to the osteocalcin promoter and activates osteocalcin expression . Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway . . |
Accessions | B1AHC9 P12956 ENST00000359308.8 [P12956-1] ENST00000405878.5 [P12956-1] ENST00000405506.2 ENST00000428575.6 ENST00000360079.8 [P12956-1] ENST00000402580.7 [P12956-2] |